Full Text View
Tabular View
Study Results
Related Studies
Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting Conditions
This study has been completed.
Study NCT01260896   Information provided by Teva Pharmaceuticals USA

First Received on December 14, 2010.   Last Updated on January 24, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial